Prelude Capital Management, LLC Poseida Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding PSTX
# of Institutions
93Shares Held
38.1MCall Options Held
255KPut Options Held
62K-
Pentwater Capital Management LP Naples, FL5.98MShares$18 Million0.2% of portfolio
-
Black Rock Inc. New York, NY4.95MShares$14.9 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.48MShares$13.5 Million0.74% of portfolio
-
Silverarc Capital Management, LLC3.6MShares$10.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.37MShares$10.2 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $259M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...